Click for best price
Pediatric Vaccines Market Size, Share 2022
Market Analysis and Insights: Global Pediatric Vaccines Market
The global Pediatric Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Vaccines market.
Global Pediatric Vaccines Scope and Market Size
Pediatric Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pediatric Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Others
Segment by Application
Newborn
Infant
Child
Dolescent
By Company
GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin
S K Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
Sinovac Biotech
Bharat Biotech
Crucell
Dynavax
Serum Institute of India
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Pediatric Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Pediatric Vaccines, with price, sales, revenue, and global market share of Pediatric Vaccines from 2019 to 2022.
Chapter 3, the Pediatric Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pediatric Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Pediatric Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pediatric Vaccines.
Chapter 13, 14, and 15, to describe Pediatric Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Pediatric Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Pediatric Vaccines Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
127 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Pediatric Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Pediatric Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pediatric Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.3.5 Dolescent
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pediatric Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Pediatric Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Pediatric Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pediatric Vaccines Sales by Region
2.4.1 Global Pediatric Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Pediatric Vaccines by Region (2023-2028)
2.5 Global Pediatric Vaccines Revenue by Region
2.5.1 Global Pediatric Vaccines Revenue by Region (2017-2022)
2.5.2 Global Pediatric Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pediatric Vaccines Sales by Manufacturers
3.1.1 Global Top Pediatric Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Pediatric Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pediatric Vaccines in 2021
3.2 Global Pediatric Vaccines Revenue by Manufacturers
3.2.1 Global Pediatric Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Pediatric Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pediatric Vaccines Revenue in 2021
3.3 Global Pediatric Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pediatric Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pediatric Vaccines Sales by Type
4.1.1 Global Pediatric Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Pediatric Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Pediatric Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Pediatric Vaccines Revenue by Type
4.2.1 Global Pediatric Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Pediatric Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pediatric Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Pediatric Vaccines Price by Type
4.3.1 Global Pediatric Vaccines Price by Type (2017-2022)
4.3.2 Global Pediatric Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pediatric Vaccines Sales by Application
5.1.1 Global Pediatric Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Pediatric Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Pediatric Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Pediatric Vaccines Revenue by Application
5.2.1 Global Pediatric Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Pediatric Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pediatric Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Pediatric Vaccines Price by Application
5.3.1 Global Pediatric Vaccines Price by Application (2017-2022)
5.3.2 Global Pediatric Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pediatric Vaccines Market Size by Type
6.1.1 North America Pediatric Vaccines Sales by Type (2017-2028)
6.1.2 North America Pediatric Vaccines Revenue by Type (2017-2028)
6.2 North America Pediatric Vaccines Market Size by Application
6.2.1 North America Pediatric Vaccines Sales by Application (2017-2028)
6.2.2 North America Pediatric Vaccines Revenue by Application (2017-2028)
6.3 North America Pediatric Vaccines Market Size by Country
6.3.1 North America Pediatric Vaccines Sales by Country (2017-2028)
6.3.2 North America Pediatric Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pediatric Vaccines Market Size by Type
7.1.1 Europe Pediatric Vaccines Sales by Type (2017-2028)
7.1.2 Europe Pediatric Vaccines Revenue by Type (2017-2028)
7.2 Europe Pediatric Vaccines Market Size by Application
7.2.1 Europe Pediatric Vaccines Sales by Application (2017-2028)
7.2.2 Europe Pediatric Vaccines Revenue by Application (2017-2028)
7.3 Europe Pediatric Vaccines Market Size by Country
7.3.1 Europe Pediatric Vaccines Sales by Country (2017-2028)
7.3.2 Europe Pediatric Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pediatric Vaccines Market Size by Type
8.1.1 Asia Pacific Pediatric Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Pediatric Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Pediatric Vaccines Market Size by Application
8.2.1 Asia Pacific Pediatric Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Pediatric Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Pediatric Vaccines Market Size by Region
8.3.1 Asia Pacific Pediatric Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Pediatric Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pediatric Vaccines Market Size by Type
9.1.1 Latin America Pediatric Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Pediatric Vaccines Revenue by Type (2017-2028)
9.2 Latin America Pediatric Vaccines Market Size by Application
9.2.1 Latin America Pediatric Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Pediatric Vaccines Revenue by Application (2017-2028)
9.3 Latin America Pediatric Vaccines Market Size by Country
9.3.1 Latin America Pediatric Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Pediatric Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Vaccines Market Size by Type
10.1.1 Middle East and Africa Pediatric Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pediatric Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Pediatric Vaccines Market Size by Application
10.2.1 Middle East and Africa Pediatric Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pediatric Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Pediatric Vaccines Market Size by Country
10.3.1 Middle East and Africa Pediatric Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pediatric Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Corporation Information
11.7.2 Takeda Pharmaceutical Overview
11.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Takeda Pharmaceutical Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Takeda Pharmaceutical Recent Developments
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Corporation Information
11.8.2 Bavarian Nordic Overview
11.8.3 Bavarian Nordic Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bavarian Nordic Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bavarian Nordic Recent Developments
11.9 Baxter
11.9.1 Baxter Corporation Information
11.9.2 Baxter Overview
11.9.3 Baxter Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Baxter Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Baxter Recent Developments
11.10 LG Life Sciences
11.10.1 LG Life Sciences Corporation Information
11.10.2 LG Life Sciences Overview
11.10.3 LG Life Sciences Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 LG Life Sciences Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 LG Life Sciences Recent Developments
11.11 Lupin
11.11.1 Lupin Corporation Information
11.11.2 Lupin Overview
11.11.3 Lupin Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Lupin Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lupin Recent Developments
11.12 S K Chemicals
11.12.1 S K Chemicals Corporation Information
11.12.2 S K Chemicals Overview
11.12.3 S K Chemicals Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 S K Chemicals Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 S K Chemicals Recent Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Corporation Information
11.13.2 Mitsubishi Tanabe Pharma Overview
11.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Mitsubishi Tanabe Pharma Recent Developments
11.14 Janssen
11.14.1 Janssen Corporation Information
11.14.2 Janssen Overview
11.14.3 Janssen Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Janssen Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Janssen Recent Developments
11.15 Shenzhen Kangtai Biological Products
11.15.1 Shenzhen Kangtai Biological Products Corporation Information
11.15.2 Shenzhen Kangtai Biological Products Overview
11.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shenzhen Kangtai Biological Products Recent Developments
11.16 Sinovac Biotech
11.16.1 Sinovac Biotech Corporation Information
11.16.2 Sinovac Biotech Overview
11.16.3 Sinovac Biotech Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Sinovac Biotech Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sinovac Biotech Recent Developments
11.17 Bharat Biotech
11.17.1 Bharat Biotech Corporation Information
11.17.2 Bharat Biotech Overview
11.17.3 Bharat Biotech Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Bharat Biotech Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Bharat Biotech Recent Developments
11.18 Crucell
11.18.1 Crucell Corporation Information
11.18.2 Crucell Overview
11.18.3 Crucell Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Crucell Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Crucell Recent Developments
11.19 Dynavax
11.19.1 Dynavax Corporation Information
11.19.2 Dynavax Overview
11.19.3 Dynavax Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Dynavax Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Dynavax Recent Developments
11.20 Serum Institute of India
11.20.1 Serum Institute of India Corporation Information
11.20.2 Serum Institute of India Overview
11.20.3 Serum Institute of India Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Serum Institute of India Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Serum Institute of India Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pediatric Vaccines Industry Chain Analysis
12.2 Pediatric Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pediatric Vaccines Production Mode & Process
12.4 Pediatric Vaccines Sales and Marketing
12.4.1 Pediatric Vaccines Sales Channels
12.4.2 Pediatric Vaccines Distributors
12.5 Pediatric Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pediatric Vaccines Industry Trends
13.2 Pediatric Vaccines Market Drivers
13.3 Pediatric Vaccines Market Challenges
13.4 Pediatric Vaccines Market Restraints
14 Key Findings in The Global Pediatric Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Pediatric Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Diphtheria
Table 3. Major Manufacturers of Influenza
Table 4. Major Manufacturers of Hepatitis
Table 5. Major Manufacturers of Pneumococcal Diseases
Table 6. Major Manufacturers of Meningococcal Diseases
Table 7. Major Manufacturers of Others
Table 8. Global Pediatric Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Pediatric Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Pediatric Vaccines Sales by Region (2017-2022) & (K Units)
Table 11. Global Pediatric Vaccines Sales Market Share by Region (2017-2022)
Table 12. Global Pediatric Vaccines Sales by Region (2023-2028) & (K Units)
Table 13. Global Pediatric Vaccines Sales Market Share by Region (2023-2028)
Table 14. Global Pediatric Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Pediatric Vaccines Revenue Market Share by Region (2017-2022)
Table 16. Global Pediatric Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Pediatric Vaccines Revenue Market Share by Region (2023-2028)
Table 18. Global Pediatric Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 19. Global Pediatric Vaccines Sales Share by Manufacturers (2017-2022)
Table 20. Global Pediatric Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Pediatric Vaccines Revenue Share by Manufacturers (2017-2022)
Table 22. Pediatric Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
Table 23. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2021)
Table 25. Pediatric Vaccines Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Pediatric Vaccines Product Offered
Table 27. Date of Manufacturers Enter into Pediatric Vaccines Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 30. Global Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 31. Global Pediatric Vaccines Sales Share by Type (2017-2022)
Table 32. Global Pediatric Vaccines Sales Share by Type (2023-2028)
Table 33. Global Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Pediatric Vaccines Revenue Share by Type (2017-2022)
Table 36. Global Pediatric Vaccines Revenue Share by Type (2023-2028)
Table 37. Pediatric Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 38. Global Pediatric Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
Table 39. Global Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 40. Global Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 41. Global Pediatric Vaccines Sales Share by Application (2017-2022)
Table 42. Global Pediatric Vaccines Sales Share by Application (2023-2028)
Table 43. Global Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Pediatric Vaccines Revenue Share by Application (2017-2022)
Table 46. Global Pediatric Vaccines Revenue Share by Application (2023-2028)
Table 47. Pediatric Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 48. Global Pediatric Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
Table 49. North America Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 50. North America Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 51. North America Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 54. North America Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 55. North America Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 58. North America Pediatric Vaccines Sales by Country (2023-2028) & (K Units)
Table 59. North America Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 62. Europe Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 63. Europe Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 66. Europe Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 67. Europe Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 70. Europe Pediatric Vaccines Sales by Country (2023-2028) & (K Units)
Table 71. Europe Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 74. Asia Pacific Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 75. Asia Pacific Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 78. Asia Pacific Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 79. Asia Pacific Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Pediatric Vaccines Sales by Region (2017-2022) & (K Units)
Table 82. Asia Pacific Pediatric Vaccines Sales by Region (2023-2028) & (K Units)
Table 83. Asia Pacific Pediatric Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Pediatric Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 86. Latin America Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 87. Latin America Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 90. Latin America Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 91. Latin America Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 94. Latin America Pediatric Vaccines Sales by Country (2023-2028) & (K Units)
Table 95. Latin America Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 98. Middle East and Africa Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 99. Middle East and Africa Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 102. Middle East and Africa Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 103. Middle East and Africa Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 106. Middle East and Africa Pediatric Vaccines Sales by Country (2023-2028) & (K Units)
Table 107. Middle East and Africa Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. GlaxoSmithKline Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. GlaxoSmithKline Recent Developments
Table 114. Merck Corporation Information
Table 115. Merck Description and Major Businesses
Table 116. Merck Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Merck Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Merck Recent Developments
Table 119. Pfizer Corporation Information
Table 120. Pfizer Description and Major Businesses
Table 121. Pfizer Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Pfizer Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Pfizer Recent Developments
Table 124. Sanofi Corporation Information
Table 125. Sanofi Description and Major Businesses
Table 126. Sanofi Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Sanofi Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Sanofi Recent Developments
Table 129. AstraZeneca Corporation Information
Table 130. AstraZeneca Description and Major Businesses
Table 131. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. AstraZeneca Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. AstraZeneca Recent Developments
Table 134. Novartis Corporation Information
Table 135. Novartis Description and Major Businesses
Table 136. Novartis Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Novartis Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Novartis Recent Developments
Table 139. Takeda Pharmaceutical Corporation Information
Table 140. Takeda Pharmaceutical Description and Major Businesses
Table 141. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Takeda Pharmaceutical Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Takeda Pharmaceutical Recent Developments
Table 144. Bavarian Nordic Corporation Information
Table 145. Bavarian Nordic Description and Major Businesses
Table 146. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Bavarian Nordic Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Bavarian Nordic Recent Developments
Table 149. Baxter Corporation Information
Table 150. Baxter Description and Major Businesses
Table 151. Baxter Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 152. Baxter Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Baxter Recent Developments
Table 154. LG Life Sciences Corporation Information
Table 155. LG Life Sciences Description and Major Businesses
Table 156. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 157. LG Life Sciences Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. LG Life Sciences Recent Developments
Table 159. Lupin Corporation Information
Table 160. Lupin Description and Major Businesses
Table 161. Lupin Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 162. Lupin Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Lupin Recent Developments
Table 164. S K Chemicals Corporation Information
Table 165. S K Chemicals Description and Major Businesses
Table 166. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 167. S K Chemicals Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. S K Chemicals Recent Developments
Table 169. Mitsubishi Tanabe Pharma Corporation Information
Table 170. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 171. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 172. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Mitsubishi Tanabe Pharma Recent Developments
Table 174. Janssen Corporation Information
Table 175. Janssen Description and Major Businesses
Table 176. Janssen Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 177. Janssen Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Janssen Recent Developments
Table 179. Shenzhen Kangtai Biological Products Corporation Information
Table 180. Shenzhen Kangtai Biological Products Description and Major Businesses
Table 181. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 182. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Shenzhen Kangtai Biological Products Recent Developments
Table 184. Sinovac Biotech Corporation Information
Table 185. Sinovac Biotech Description and Major Businesses
Table 186. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 187. Sinovac Biotech Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Sinovac Biotech Recent Developments
Table 189. Bharat Biotech Corporation Information
Table 190. Bharat Biotech Description and Major Businesses
Table 191. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 192. Bharat Biotech Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Bharat Biotech Recent Developments
Table 194. Crucell Corporation Information
Table 195. Crucell Description and Major Businesses
Table 196. Crucell Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 197. Crucell Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Crucell Recent Developments
Table 199. Dynavax Corporation Information
Table 200. Dynavax Description and Major Businesses
Table 201. Dynavax Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 202. Dynavax Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Dynavax Recent Developments
Table 204. Serum Institute of India Corporation Information
Table 205. Serum Institute of India Description and Major Businesses
Table 206. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 207. Serum Institute of India Pediatric Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 208. Serum Institute of India Recent Developments
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. Pediatric Vaccines Distributors List
Table 212. Pediatric Vaccines Customers List
Table 213. Pediatric Vaccines Market Trends
Table 214. Pediatric Vaccines Market Drivers
Table 215. Pediatric Vaccines Market Challenges
Table 216. Pediatric Vaccines Market Restraints
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Vaccines Product Picture
Figure 3. Global Pediatric Vaccines Market Share by Type in 2021 & 2028
Figure 3. Diphtheria Product Picture
Figure 4. Influenza Product Picture
Figure 5. Hepatitis Product Picture
Figure 6. Pneumococcal Diseases Product Picture
Figure 7. Meningococcal Diseases Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pediatric Vaccines Market Share by Application in 2021 & 2028
Figure 10. Newborn
Figure 11. Infant
Figure 12. Child
Figure 13. Dolescent
Figure 14. Pediatric Vaccines Report Years Considered
Figure 15. Global Pediatric Vaccines Sales 2017-2028 (K Units)
Figure 16. Global Pediatric Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Pediatric Vaccines Revenue 2017-2028 (US$ Million)
Figure 18. Global Pediatric Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Pediatric Vaccines Sales Market Share by Region (2017-2022)
Figure 20. Global Pediatric Vaccines Sales Market Share by Region (2023-2028)
Figure 21. North America Pediatric Vaccines Sales YoY (2017-2028) & (K Units)
Figure 22. North America Pediatric Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Pediatric Vaccines Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Pediatric Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Pediatric Vaccines Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Pediatric Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Pediatric Vaccines Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Pediatric Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Pediatric Vaccines Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Pediatric Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Pediatric Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Pediatric Vaccines in the World: Market Share by Pediatric Vaccines Revenue in 2021
Figure 33. Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Pediatric Vaccines Sales Market Share by Type (2017-2028)
Figure 35. Global Pediatric Vaccines Revenue Market Share by Type (2017-2028)
Figure 36. Global Pediatric Vaccines Sales Market Share by Application (2017-2028)
Figure 37. Global Pediatric Vaccines Revenue Market Share by Application (2017-2028)
Figure 38. North America Pediatric Vaccines Sales Market Share by Type (2017-2028)
Figure 39. North America Pediatric Vaccines Revenue Market Share by Type (2017-2028)
Figure 40. North America Pediatric Vaccines Sales Market Share by Application (2017-2028)
Figure 41. North America Pediatric Vaccines Revenue Market Share by Application (2017-2028)
Figure 42. North America Pediatric Vaccines Sales Share by Country (2017-2028)
Figure 43. North America Pediatric Vaccines Revenue Share by Country (2017-2028)
Figure 44. U.S. Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Pediatric Vaccines Sales Market Share by Type (2017-2028)
Figure 47. Europe Pediatric Vaccines Revenue Market Share by Type (2017-2028)
Figure 48. Europe Pediatric Vaccines Sales Market Share by Application (2017-2028)
Figure 49. Europe Pediatric Vaccines Revenue Market Share by Application (2017-2028)
Figure 50. Europe Pediatric Vaccines Sales Share by Country (2017-2028)
Figure 51. Europe Pediatric Vaccines Revenue Share by Country (2017-2028)
Figure 52. Germany Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 53. France Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Pediatric Vaccines Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Pediatric Vaccines Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Pediatric Vaccines Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Pediatric Vaccines Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Pediatric Vaccines Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Pediatric Vaccines Revenue Share by Region (2017-2028)
Figure 63. China Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. India Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. China Taiwan Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Pediatric Vaccines Sales Market Share by Type (2017-2028)
Figure 73. Latin America Pediatric Vaccines Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Pediatric Vaccines Sales Market Share by Application (2017-2028)
Figure 75. Latin America Pediatric Vaccines Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Pediatric Vaccines Sales Share by Country (2017-2028)
Figure 77. Latin America Pediatric Vaccines Revenue Share by Country (2017-2028)
Figure 78. Mexico Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 81. Colombia Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Pediatric Vaccines Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Pediatric Vaccines Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Pediatric Vaccines Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Pediatric Vaccines Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Pediatric Vaccines Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Pediatric Vaccines Revenue Share by Country (2017-2028)
Figure 88. Turkey Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 90. UAE Pediatric Vaccines Revenue (2017-2028) & (US$ Million)
Figure 91. Pediatric Vaccines Value Chain
Figure 92. Pediatric Vaccines Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
